Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2001 1
2002 2
2006 3
2007 2
2009 3
2010 3
2011 1
2012 3
2013 4
2014 9
2015 6
2016 12
2017 9
2018 10
2019 11
2020 10
2021 7
2022 8
2023 8
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.
Powles T, Csőszi T, Özgüroğlu M, Matsubara N, Géczi L, Cheng SY, Fradet Y, Oudard S, Vulsteke C, Morales Barrera R, Fléchon A, Gunduz S, Loriot Y, Rodriguez-Vida A, Mamtani R, Yu EY, Nam K, Imai K, Homet Moreno B, Alva A; KEYNOTE-361 Investigators. Powles T, et al. Lancet Oncol. 2021 Jul;22(7):931-945. doi: 10.1016/S1470-2045(21)00152-2. Epub 2021 May 26. Lancet Oncol. 2021. PMID: 34051178 Clinical Trial.
Patient-centered interpretation services.
Francisco F, Harris A. Francisco F, et al. Radiol Technol. 2009 May-Jun;80(5):477-80. Radiol Technol. 2009. PMID: 19457852 No abstract available.
Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients.
Barroso-García N, Atienza-Mateo B, Ferraz-Amaro I, Prieto-Peña D, Beltrán E, Adán A, Hernández-Garfella M, Martínez-Costa L, Cordero-Coma M, Díaz-Llopis M, Herreras JM, Maíz-Alonso O, Torre-Salaberri I, De Vicente-Delmás A, Díaz-Valle D, Atanes-Sandoval A, Francisco F, Insua S, Sánchez J, Almodóvar-González R, Jiménez-Sosa A, Ruiz-Moreno O, Gandía-Martínez M, Nolla JM, Calvo-Río V, Castañeda S, González-Gay MA, Blanco R. Barroso-García N, et al. Among authors: francisco f. Semin Arthritis Rheum. 2023 Feb;58:152153. doi: 10.1016/j.semarthrit.2022.152153. Epub 2022 Dec 14. Semin Arthritis Rheum. 2023. PMID: 36549244 Review.
Timing decisions as the next frontier for collective intelligence.
Kao AB, Banerjee SC, Francisco FA, Berdahl AM. Kao AB, et al. Among authors: francisco fa. Trends Ecol Evol. 2024 Oct;39(10):904-912. doi: 10.1016/j.tree.2024.06.003. Epub 2024 Jul 3. Trends Ecol Evol. 2024. PMID: 38964933 Free article. Review.
Acephate exposure during a perinatal life program to type 2 diabetes.
Ribeiro TA, Prates KV, Pavanello A, Malta A, Tófolo LP, Martins IP, Oliveira JC, Miranda RA, Gomes RM, Vieira E, Franco CC, Barella LF, Francisco FA, Alves VS, Silveira SD, Moreira VM, Fabricio GS, Palma-Rigo K, Sloboda DM, Mathias PC. Ribeiro TA, et al. Among authors: francisco fa. Toxicology. 2016 Nov 30;372:12-21. doi: 10.1016/j.tox.2016.10.010. Epub 2016 Oct 17. Toxicology. 2016. PMID: 27765684 Review.
101 results